CCR1 and CCR5 expression on inflammatory cells is related to cigarette smoking and chronic obstructive pulmonary disease severity

Chinese Medical Journal

Volumn 125, Issue 23, 2012, Pages 4277-4282

  Wang, Fei ^a   He, Bei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

CCR1; CCR5; Chronic obstructive; Inflammation; Pulmonary disease; Receptors; Smoke

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MALE; PROTEIN EXPRESSION; SMOKING; SPUTUM EXAMINATION;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CCR1; RECEPTORS, CCR5; SMOKING; SPUTUM;

EID: 84870731404     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.23.021     Document Type: Article

References (26)

1. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469-473.
2. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-826.
3. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998; 12: 380-386.
4. Keatings VW, Collings PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease of asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
5. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. Asthma Epidemiology Study Group. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006; 48: 23-29.
6. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160 (5 Pt 2): S29-S32.
7. Stefano AD, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, et al. Severity of airway limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158: 1277-1285.
8. Jeffery PK. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Found Symp 2001; 234: 149-161.
9. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002; 121 (5 Suppl): 160S-165S.
10. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
11. Peleman RA, Rytila PH, Kips JC, Joos GF, Pauwels RA. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 839-843.
12. Hogg JC, Chu F, Utokaparch S, Woods R. The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
13. O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Brogerg P, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004; 59: 837-842.
14. -/-mice during chronic fungal allergic airway disease. J Immunol 2000; 165: 1564-1572.
15. Hartl D, Krauss-Etschmann S, Koller B, Hordijk PL, Kuijpers TW, Bittmann I, et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J Immunol 2008; 181: 8053-8067.
16. De Boer WI. Cytokines and therapy in COPD. Chest 2002; 121 (5 Suppl): 209S-218S.
17. Onnervik PO, Lindahl M, Svitacheva N, Stämpfli M, Thim K, Smailagic A, et al. The role of the CCR1 receptor in the inflammatory response to tobacco smoke in a mouse model. Inflamm Res 2010; 59: 817-825.
18. + cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 2007; 171: 767-776.
19. Li YT, He B, Wang YZ, Wang J. Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice. Respir Res 2009; 10: 79-92.
20. Global Initiative for Chronic Obstructive Lung Disease 2009. (Accessed September 12, 2011 at http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=2003)
21. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridization. Eur Respir J Suppl 2002; 37: 19s-23s.
22. Nightingale JA, Maggs R, Cullinan P, Donnelly LE, Rogers DF, Kinnersley R, et al. Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med 2000; 162: 161-166.
23. Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99: 703-710.
24. Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15: 109-115.
25. Joubert P, Lajoie-Kadoch S, Welman M, Dragon S, Létuvée S, Tolloczko B, et al. Expression and regulation of CCR1 by airway smooth muscle cells in asthma. J Immunol 2008; 180: 1268-1275.
26. Yung RL, Mo R. Aging is associated with increased human T cell CC chemokine receptor gene expression. J Interferon Cytokine Res 2003; 23: 575-582.